JPRN-UMIN000013213招募中未知
Effect of on combination therapy with irbesartan and amlodipine besilate on clinical blood pressure, home blood pressure and blood pressure variability in hypertensive patients with chronic kidney disease - Effect of combination therapy with irbesartan and amlodipine besilate on hypertensive patients with chronic kidney disease
Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine0 个研究点目标入组 30 人开始时间: 2014年2月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) CKD G5 or dialysis patients. 2) Patients who have allergy for amlodipine besilate or irbesartan. 3) Patients who are pregnant. 4) Patients judged as inappropriate for the study.
研究者
相似试验
已完成
4 期
Effects of the combination therapy of irbesartan and indapamide in chronik kidney disease with hypertensiochronick kidney disease with hypertensionJPRN-UMIN000010787Division of Nephrology, Department of Internal medicine, Jichi Medical University30
进行中（未招募）
不适用
Irbesartan versus Placebo in Combination with Standard Cardiovascular Protection ACE-I Therapy with Ramipril for the Treatment of Hypertensive Albuminuria in Subjects at Elevated Cardiovascular Risk - IMPROVEEUCTR2004-000022-75-LVBristol-Myers Squibb International Corporation615
进行中（未招募）
不适用
Irbesartan Versus Placebo in Combination with Standard Cardiovascular Protection ACE-I Therapy with Ramipril for the Treatment of Albuminuria in Hypertensive Subjects at Elevated Cardiovascular Risk - IMPROVEAlbuminuria in hypertensive subjects at increased cardiovascular risk.EUCTR2004-000022-75-LTBristol-Myers Squibb International Corporation615
进行中（未招募）
1 期
Irbesartan Versus Placebo in Combination with Standard Cardiovascular Protection ACE-I Therapy with Ramipril for the Treatment of Albuminuria in Subjects at Elevated Cardiovascular Risk - IMPROVEEUCTR2004-000022-75-ESBristol-Myers Squibb International Corporation615
进行中（未招募）
不适用
Irbesartan Versus Placebo in Combination with Standard Cardiovascular Protection ACE-I Therapy with Ramipril for the Treatment of Albuminuria in Hypertensive Subjects at Elevated Cardiovascular Risk.EUCTR2004-000022-75-ITBRISTOL-M.SQUIBB600